| scholarly article | Q13442814 |
| P50 | author | Ross Zafonte | Q7369727 |
| Ted J Kaptchuk | Q7693360 | ||
| Mary Alexis Iaccarino | Q125252102 | ||
| Ginger Polich | Q125252119 | ||
| P2093 | author name string | Leon Morales-Quezada | |
| P2860 | cites work | Sertraline for Major Depression During the Year Following Traumatic Brain Injury: A Randomized Controlled Trial | Q47882654 |
| Mobile phone text messaging to assess symptoms after mild traumatic brain injury and provide self-care support: a pilot study | Q48132670 | ||
| Influence of poor effort on self-reported symptoms and neurocognitive test performance following mild traumatic brain injury | Q48213546 | ||
| Mobilizing unused resources: using the placebo concept to enhance cognitive performance | Q48337999 | ||
| Effects of rivastigmine on cognitive function in patients with traumatic brain injury | Q48423303 | ||
| Analysis of 34 candidate genes in bupropion and placebo remission | Q48617573 | ||
| Heart Rate Variability of Athletes Across Concussion Recovery Milestones: A Preliminary Study | Q48638655 | ||
| Placebo 'serotonin' increases heart rate variability in recovery from psychosocial stress. | Q50591251 | ||
| COMT Val158Met and cognitive and functional outcomes after traumatic brain injury. | Q50666166 | ||
| The effects of physicians' affect-oriented communication style and raising expectations on analogue patients' anxiety, affect and expectancies. | Q50677992 | ||
| Influence of a Suggestive Placebo Intervention on Psychobiological Responses to Social Stress: A Randomized Controlled Trial. | Q50908269 | ||
| The effect of telephone counselling on reducing post-traumatic symptoms after mild traumatic brain injury: a randomised trial. | Q51964864 | ||
| Stress as a diagnostic challenge for postconcussive symptoms: sequelae of mild traumatic brain injury or physiological stress response. | Q52015298 | ||
| Classical conditioning and the placebo effect. | Q52193248 | ||
| The role of conditioning and verbal expectancy in the placebo response. | Q52239898 | ||
| Commercial features of placebo and therapeutic efficacy. | Q55048934 | ||
| How prior experience shapes placebo analgesia | Q59510224 | ||
| Placebo Effects in Medicine | Q60304535 | ||
| Pills and improvement: A study of placebo response in psychoneurotic outpatients | Q69900669 | ||
| The influence of the patient-clinician relationship on healthcare outcomes: a systematic review and meta-analysis of randomized controlled trials | Q21132063 | ||
| Catechol-O-methyltransferase val158met polymorphism predicts placebo effect in irritable bowel syndrome | Q21133920 | ||
| Sham device v inert pill: randomised controlled trial of two placebo treatments | Q24537565 | ||
| Analgesic effects of branding in treatment of headaches | Q24551033 | ||
| Active albuterol or placebo, sham acupuncture, or no intervention in asthma | Q24619275 | ||
| Neurobiological mechanisms of placebo responses | Q24621444 | ||
| Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome | Q24647883 | ||
| Placebo effects: clinical aspects and neurobiology | Q24653735 | ||
| Site-specific role of catechol-O-methyltransferase in dopamine overflow within prefrontal cortex and dorsal striatum | Q28249776 | ||
| Monoamine oxidase a and catechol-o-methyltransferase functional polymorphisms and the placebo response in major depressive disorder | Q28251587 | ||
| Randomized trial of the effect of drug presentation on asthma outcomes: the American Lung Association Asthma Clinical Research Centers | Q33487035 | ||
| Persistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesis | Q33589580 | ||
| Patient and practitioner influences on the placebo effect in irritable bowel syndrome | Q33636363 | ||
| Biological, clinical, and ethical advances of placebo effects | Q33703954 | ||
| Certainty of genuine treatment increases drug responses among intellectually disabled patients | Q33726997 | ||
| Are sham acupuncture interventions more effective than (other) placebos? A re-analysis of data from the Cochrane review on placebo effects | Q33730112 | ||
| Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial | Q33730499 | ||
| Network analysis of the genomic basis of the placebo effect | Q33752381 | ||
| Placebo analgesia and reward processing: integrating genetics, personality, and intrinsic brain activity | Q33934473 | ||
| The powerful placebo | Q33969075 | ||
| Do medical devices have enhanced placebo effects? | Q34003166 | ||
| Nocebo-induced hyperalgesia during local anesthetic injection. | Q34020725 | ||
| Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease | Q34086449 | ||
| The placebo effect in alternative medicine: can the performance of a healing ritual have clinical significance? | Q34131341 | ||
| Influence of context effects on health outcomes: a systematic review. | Q34186909 | ||
| Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. | Q34199513 | ||
| How the number of learning trials affects placebo and nocebo responses | Q34204013 | ||
| Is the placebo powerless? Update of a systematic review with 52 new randomized trials comparing placebo with no treatment | Q34333919 | ||
| Differential effectiveness of placebo treatments: a systematic review of migraine prophylaxis. | Q34377710 | ||
| Placebo Responses in Genetically Determined Intellectual Disability: A Meta-Analysis | Q34487591 | ||
| Placebo effects on the immune response in humans: the role of learning and expectation | Q34490082 | ||
| Loss of expectation-related mechanisms in Alzheimer's disease makes analgesic therapies less effective | Q34493774 | ||
| Conditioned response models of placebo phenomena: further support | Q34543839 | ||
| Individual differences in reward responding explain placebo-induced expectations and effects | Q34653689 | ||
| What Happened at Hawthorne?: New evidence suggests the Hawthorne effect resulted from operant reinforcement contingencies | Q34672356 | ||
| Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses | Q34746177 | ||
| The placebo treatments in neurosciences: New insights from clinical and neuroimaging studies | Q34813184 | ||
| A link between serotonin-related gene polymorphisms, amygdala activity, and placebo-induced relief from social anxiety. | Q34893258 | ||
| How placebo responses are formed: a learning perspective | Q35088475 | ||
| The placebo effect and the autonomic nervous system: evidence for an intimate relationship | Q35088492 | ||
| Placebo improvement in pharmacologic treatment of menopausal hot flashes: time course, duration, and predictors | Q35097020 | ||
| Placebo effect of medication cost in Parkinson disease: a randomized double-blind study | Q35134917 | ||
| Impact of early intervention on outcome following mild head injury in adults | Q35468756 | ||
| Conditioned placebo analgesia persists when subjects know they are receiving a placebo | Q35582578 | ||
| Patient-Provider Interactions Affect Symptoms in Gastroesophageal Reflux Disease: A Pilot Randomized, Double-Blind, Placebo-Controlled Trial | Q35793789 | ||
| Classical conditioning of analgesic and hyperalgesic pain responses without conscious awareness | Q35796104 | ||
| Placebo mechanisms and reward circuitry: clues from Parkinson's disease. | Q35825195 | ||
| Amantadine Effect on Perceptions of Irritability after Traumatic Brain Injury: Results of the Amantadine Irritability Multisite Study | Q35910904 | ||
| A Neural Mechanism for Nonconscious Activation of Conditioned Placebo and Nocebo Responses | Q36098822 | ||
| Nonconscious activation of placebo and nocebo pain responses | Q36300833 | ||
| Neurobehavioral sequelae of traumatic brain injury: evaluation and management | Q36575384 | ||
| Personality trait predictors of placebo analgesia and neurobiological correlates | Q36610049 | ||
| Serotonin transporter genotype and mild traumatic brain injury independently influence resilience and perception of limitations in veterans | Q36813696 | ||
| COMT Val 158 Met polymorphism is associated with nonverbal cognition following mild traumatic brain injury | Q37184068 | ||
| Reconsidering the placebo response from a broad anthropological perspective. | Q37314600 | ||
| Trust in the health care professional and health outcome: A meta-analysis. | Q37629429 | ||
| Systematic review of the Hawthorne effect: new concepts are needed to study research participation effects | Q37671448 | ||
| The placebo effect: From concepts to genes. | Q37723087 | ||
| Placebo studies and ritual theory: a comparative analysis of Navajo, acupuncture and biomedical healing | Q37876001 | ||
| The placebo response: how words and rituals change the patient's brain | Q37881388 | ||
| A review of the psychotherapeutic 'common factors' model and its application in physical therapy: the need to consider general effects in physical therapy practice | Q37931328 | ||
| Is rest after concussion "the best medicine?": recommendations for activity resumption following concussion in athletes, civilians, and military service members. | Q38017891 | ||
| Great expectations: the placebo effect in Parkinson's disease | Q38259033 | ||
| Placebo responses on cardiovascular, gastrointestinal, and respiratory organ functions | Q38259036 | ||
| A systematic review found no consistent difference in effect between more and less intensive placebo interventions | Q38339707 | ||
| The nature of placebo response in clinical studies of major depressive disorder | Q38362925 | ||
| Autonomic dysfunction syndromes after acute brain injury | Q38363451 | ||
| Genetics and the placebo effect: the placebome | Q38425277 | ||
| The neuroscience of placebo effects: connecting context, learning and health | Q38531270 | ||
| Prolonged Activity Restriction After Concussion: Are We Worsening Outcomes? | Q38541150 | ||
| Placebo Medication and Sham Surgery Responses in Benign Prostatic Hyperplasia Treatments: Implications for Clinical Trials. | Q38573073 | ||
| Invalid symptom reporting and performance: What are we missing? | Q38593449 | ||
| On the importance of placebo timing in rTMS studies for pain relief | Q39270722 | ||
| A sham drug improves a demanding prospective memory task | Q39707402 | ||
| A randomized controlled trial of sertraline for the treatment of depression in persons with traumatic brain injury | Q39883209 | ||
| Teaching neurons to respond to placebos | Q40009826 | ||
| The serotonin transporter polymorphisms and major depression following traumatic brain injury | Q40094235 | ||
| No effect of an early intervention after mild traumatic brain injury on activity and participation: A randomized controlled trial | Q40356326 | ||
| COMT Val158Met polymorphism is associated with post-traumatic stress disorder and functional outcome following mild traumatic brain injury. | Q40524913 | ||
| Frontal-subcortical circuits and neuropsychiatric disorders | Q40582849 | ||
| Postconcussion symptoms and daily stress in normal and head-injured college populations | Q41127034 | ||
| Classical conditioning without verbal suggestions elicits placebo analgesia and nocebo hyperalgesia. | Q41153445 | ||
| COMT and ANKK1 Genetics Interact With Depression to Influence Behavior Following Severe TBI: An Initial Assessment | Q42646963 | ||
| The placebo-reward hypothesis: dopamine and the placebo effect | Q43190940 | ||
| Nonspecific effects in longitudinal studies: impact on quality of life measures | Q43744819 | ||
| The effect of treatment expectation on drug efficacy: imaging the analgesic benefit of the opioid remifentanil | Q44349496 | ||
| Placebo analgesia and the heart | Q44349854 | ||
| Variants of SLC6A4 in depression risk following severe TBI. | Q44702295 | ||
| Heart rate variability in neurorehabilitation patients with severe acquired brain injury | Q45133364 | ||
| Early intervention for patients at risk for persisting disability after mild traumatic brain injury: a randomized, controlled study. | Q46234888 | ||
| The roles of physiological and subjective stress in the effectiveness of a placebo on experimentally induced pain | Q46272107 | ||
| Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype | Q46430940 | ||
| The effect of treatment history on therapeutic outcome: an experimental approach | Q46781241 | ||
| Association of COMT Val158Met genotype with executive functioning following traumatic brain injury | Q46875336 | ||
| Neural mechanisms of placebo anxiolysis. | Q47700367 | ||
| P433 | issue | 11 | |
| P921 | main subject | placebo | Q269829 |
| P304 | page(s) | 1205-1212 | |
| P577 | publication date | 2018-04-05 | |
| P1433 | published in | Journal of Neurotrauma | Q15716774 |
| P1476 | title | Placebo Effects in Traumatic Brain Injury | |
| P478 | volume | 35 |
| Q58700205 | Amantadine Did Not Positively Impact Cognition in Chronic Traumatic Brain Injury: A Multi-Site, Randomized, Controlled Trial |
| Q64110559 | Antidepressants for depression after concussion and traumatic brain injury are still best practice |
| Q89525264 | Does patient expectancy account for the cognitive and clinical benefits of mindfulness training in older adults? |
| Q64235307 | Herbal medicine for acute management and rehabilitation of traumatic brain injury: A protocol for a systematic review |
Search more.